We are live on
!
Find out more
RL
Ruffer LLP Portfolio holdings
AUM
$2.44B
1-Year Est. Return
44.75%
This Fund
S&P 500
This Quarter
Est. Return
+18.22%
1 Year Est. Return
+44.75%
3 Year Est. Return
+105.9%
5 Year Est. Return
+158.64%
10 Year Est. Return
+642.68%
AUM
$3.43B
AUM Growth
-$91.6M
(-2.6%)
Cap. Flow
-$572M
Cap. Flow
% of AUM
-16.67%
Top 10 Holdings %
Top 10 Hldgs %
62.86%
Holding
98
New
5
Increased
18
Reduced
40
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$294M |
| 2 |
Freeport-McMoran
FCX
|
+$172M |
| 3 |
eHealth
EHTH
|
+$76.5M |
| 4 |
Dow Inc
DOW
|
+$55.4M |
| 5 |
General Motors
GM
|
+$38.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$318M |
| 2 |
Amgen
AMGN
|
+$218M |
| 3 |
Walt Disney
DIS
|
+$133M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$111M |
| 5 |
Cigna
CI
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 32.47% |
| 2 | Healthcare | 23.38% |
| 3 | Communication Services | 13.54% |
| 4 | Energy | 13.02% |
| 5 | Consumer Discretionary | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Walt Disney
DIS
$165B
| $462M | 13.48% |
3,195,119
-953,270
| -23% | -$133M |
|
|
2
Bristol-Myers Squibb
BMY
$127B
| $337M | 9.83% |
5,253,374
+5,135,274
| +4,348% | +$294M |
|
|
3
Freeport-McMoran
FCX
$90B
| $220M | 6.41% |
16,724,976
+15,628,927
| +1,426% | +$172M |
|
4
ExxonMobil
XOM
$651B
| $199M | 5.81% |
2,851,928
-599,351
| -17% | -$41.4M |
|
5
Kinross Gold
KGC
$28.5B
| $199M | 5.8% |
41,893,161
+1,557,682
| +4% | +$7.03M |
|
6
NOV
NOV
$7.45B
| $178M | 5.18% |
7,089,186
-104,331
| -1% | -$2.35M |
|
|
7
Cigna
CI
$76.6B
| $164M | 4.77% |
799,501
-587,272
| -42% | -$108M |
|
8
Centene
CNC
$31.3B
| $160M | 4.66% |
2,540,551
-288,403
| -10% | -$15.6M |
|
9
Wheaton Precious Metals
WPM
$50.6B
| $126M | 3.67% |
4,225,971
-30,688
| -0.7% | -$839K |
|
|
10
General Motors
GM
$74.7B
| $111M | 3.24% |
3,036,570
+1,067,771
| +54% | +$38.8M |
|
|
FL
11
DELISTED
Foot Locker
FL
| $108M | 3.15% |
2,770,975
-1,005,705
| -27% | -$42.4M |
|
12
Humana
HUM
$46.7B
| $102M | 2.97% |
277,936
-108,612
| -28% | -$34.4M |
|
|
13
eHealth
EHTH
$42.5M
| $94.7M | 2.76% |
+985,957
| New | +$76.5M |
|
14
Newmont
NEM
$98.2B
| $91.1M | 2.66% |
2,096,743
+59,761
| +3% | +$2.34M |
|
|
ATVI
15
DELISTED
Activision Blizzard
ATVI
| $90.6M | 2.64% |
1,523,788
-2,001,932
| -57% | -$111M |
|
16
IAMGOLD
IAG
$8.47B
| $81.3M | 2.37% |
21,698,088
+645,028
| +3% | +$2.28M |
|
|
17
Dow Inc
DOW
$21.6B
| $72.1M | 2.1% |
1,317,649
+1,072,714
| +438% | +$55.4M |
|
18
AngloGold Ashanti
AU
$40.3B
| $70.8M | 2.06% |
3,166,016
-85,539
| -3% | -$1.72M |
|
|
VAL
19
DELISTED
Valaris plc Class A Ordinary Share
VAL
| $64.3M | 1.88% |
9,812,973
+2,016,343
| +26% | +$9.83M |
|
20
Gold Fields
GFI
$29.2B
| $51.3M | 1.5% |
7,767,105
-794,010
| -9% | -$4.5M |
|
21
Synchrony
SYF
$23.7B
| $48.9M | 1.43% |
1,358,735
-153,161
| -10% | -$5.48M |
|
|
B
22
Barrick Mining
B
$62.2B
| $47.6M | 1.39% |
2,563,928
+479,741
| +23% | +$8.23M |
|
23
Check Point Software Technologies
CHKP
$13.3B
| $34.4M | 1% |
309,526
-9,281
| -3% | -$1.04M |
|
|
LTHM
24
DELISTED
Livent Corporation
LTHM
| $32.6M | 0.95% |
3,814,666
-17,441
| -0.5% | -$133K |
|
25
DuPont de Nemours
DD
$18.6B
| $26.6M | 0.77% |
329,441
+66,326
| +25% | +$5.51M |
|
Similar funds
QT
TMC
GWM
KFA
BW
M
BBA
PUI
Ruffer LLP's Q4 2019 Portfolio in Review
As of Q4 2019, Ruffer LLP held 98 positions worth $3.43B, down 2.6% from $3.52B the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Ruffer LLP withdrew a net $572M in Q4 2019, closing 17 positions and reducing 40 holdings. Its most notable exit was Celgene Corp, an estimated $318M position sold in full.
By sector, the portfolio is most concentrated in Materials at 32% of assets, up from 24% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Ruffer LLP opened a new position in eHealth worth $94.7M.
- Ruffer LLP's largest Q4 2019 buy was eHealth: 985,957 shares worth $94.7M.
- Ruffer LLP added most to Bristol-Myers Squibb in Q4 2019, an estimated $294M increase.
- Ruffer LLP's biggest Q4 2019 reduction was Amgen, cutting an estimated $218M.
- Ruffer LLP fully exited Celgene Corp in Q4 2019, selling an estimated $318M.
- Ruffer LLP's ten largest holdings make up 63% of its $3.43B portfolio in Q4 2019.
- Ruffer LLP opened 5 new positions and closed 17 in Q4 2019.
- Ruffer LLP's portfolio value fell 2.6% quarter-over-quarter to $3.43B.
Based on Ruffer LLP's 13F filing for Q4 2019, filed 6 Feb 2020.